Eris Pharmaceuticals Limited
About Eris Pharmaceuticals Limited
Data last updated:
Eris Pharmaceuticals Limited is a public limited company based in Fatehpur Roshnai, Uttar Pradesh, India, a subsidiary of Eris Healthcare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33100UP2020PLC128964. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Inderjeet Singh Negi and Kaushal Kamlesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Fatehpur Roshnai, Uttar Pradesh.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressArazi No. 1554, Vill Sachendi Kalpi Road, Fatehpur Roshnai, Uttar Pradesh, India – 209304
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eris Pharmaceuticals Limited
The main business activity of Eris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Eris Pharmaceuticals Limited FY 2024 filings available
Financial Statement Summary of Eris Pharmaceuticals Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Eris Pharmaceuticals Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eris Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Eris Pharmaceuticals Limited
Eris Pharmaceuticals Limited is audited by RRS & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RRS & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eris Pharmaceuticals Limited
Eris Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inderjeet Singh Negi Also directs: Eris Lifesciences Limited, Eris Healthcare Private Limited, Eris Therapeutics Limited and 3 more | Director | 30 Jul 2024 | 2 Years 2 Months | Current |
| Kaushal Kamlesh Shah Also directs: Eris Lifesciences Limited, Eris Healthcare Private Limited, Eris Therapeutics Limited and 5 more | Director | 30 Jul 2024 | 2 Years 2 Months | Current |
| Sachin Shah Also directs: Eris Healthcare Private Limited, Eris Therapeutics Limited, Aprica Healthcare Limited and 4 more | Director | 30 Jul 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Eris Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eris Pharmaceuticals Limited
Eris Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Eris Pharmaceuticals Limited
Eris Pharmaceuticals Limited has a workforce of 0 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Eris Pharmaceuticals Limited
Eris Pharmaceuticals has one previous CIN (Corporate Identification Number): U33100UP2020PTC128964. The current CIN is U33100UP2020PLC128964, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33100UP2020PLC128964 | Current |
| U33100UP2020PTC128964 | Previous |
Recent Activity on Eris Pharmaceuticals Limited
Eris Pharmaceuticals Limited has 9 board changes on record since 2024: 3 appointments and 6 cessations. The latest: Inderjeet Singh Negi ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Eris Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eris Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eris Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eris Pharmaceuticals Limited
Eris Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eris Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eris Pharmaceuticals Limited
Eris Pharmaceuticals is an active public limited company based in Fatehpur Roshnai, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 2020 (6+ years old) and is registered under CIN U33100UP2020PLC128964.
Eris Pharmaceuticals has 3 current directors:
- Inderjeet Singh Negi - Director
- Kaushal Kamlesh Shah - Director
- Sachin Shah - Director
No. Eris Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Eris Pharmaceuticals is U33100UP2020PLC128964. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eris Pharmaceuticals was incorporated on 02 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
Inderjeet Singh Negi ceased to be Additional Director on 29 Sep 2024. Kaushal Kamlesh Shah ceased to be Additional Director on 29 Sep 2024. Sachin Shah ceased to be Additional Director on 29 Sep 2024. Eris Pharmaceuticals has 9 board changes on record in total.
The registered office of Eris Pharmaceuticals is at Arazi No. 1554, Vill Sachendi Kalpi Road, Fatehpur Roshnai, Uttar Pradesh, India – 209304.
Eris Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Eris Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
No. Eris Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.